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Abstract.  Vaccinia virus,  the prototype of the Poxviri- 
dae,  is a large DNA virus which replicates in the 
cytoplasm of the host cell. The assembly pathway of 
vaccinia virus displays several unique features,  such as 
the production of two structurally distinct,  infectious 
forms. One of these, termed intracellular  naked virus 
(INV), remains cell associated while the other,  termed 
extracellular enveloped virus (EEV),  is released from 
the cell.  In addition,  it has long been believed that 
INVs acquire their lipid envelopes by a unique exam- 
ple of de novo membrane biogenesis. To examine the 
structure and assembly of vaccinia virus we have used 
immunoelectron microscopy using antibodies to pro- 
teins of different subcellular compartments as well as a 
phospholipid analysis of purified INV and EEV.  Our 
data are not consistent with the de novo model of viral 
membrane synthesis but rather argue that the vaccinia 
virus DNA becomes enwrapped by a membrane 
cisterna derived from the intermediate compartment 
between the ER and the Golgi stacks, thus acquiring 
two membranes in one step. Phospholipid analysis of 
purified INV supports its derivation from an early bio- 
synthetic compartment.  This unique assembly process 
is repeated once more when the INV becomes en- 
wrapped by an additional membrane cisterna,  in 
agreement with earlier reports.  The available data sug- 
gest that after fusion between the outer envelope and 
the plasma membrane,  mature EEV is released from 
the cell. 
V 
ACCINIA virus  is  the  best  studied  member  of the 
family Poxviridae, the largest and most complex of 
the animal viruses (for reviews see Dales and Pogo, 
1981; Fenner et al., 1989; Moss, 1991). Its double-stranded 
linear DNA genome of 191 kbp has been sequenced and 263 
potential  genes have been identified  (Goebel et al.,  1990). 
Unlike other DNA viruses, vaccinia virus replicates and as- 
sembles in the cytoplasm of the host cell.  Both replication 
and assembly occur in discrete cytoplasmic foci termed viral 
factories which  are thought  to be devoid of cellular  or- 
ganelles and membranes (Joklik and Becker,  1964). Assem- 
bly is first manifested by the appearance of crescent-shaped 
membranes  within  the viral  factories.  These  membranes 
eventually form spherical,  immature virions which undergo 
additional  maturational  events, including the cleavage of vi- 
ral core proteins (Moss and Rosenblum,  1973), to give rise 
to the first infectious,  brick-shaped form of vaccinia  virus 
(Dales and Pogo,  1981). This viral  form is by far the best 
characterized  and has long been referred  to as intracellular 
"naked" virus (INV)  1 despite the fact that it is bound by at 
least one lipid  envelope.  Phospholipid  comprises "~5 % of 
the INV by weight (Zwartouw,  1964) and disruption of the 
envelope by nonionic detergent increases its apparent density 
in cesium chloride gradients (Doms et al., 1990). A variable 
amount of the INV is thought to be transported to the Golgi 
region of the cell (Ichihashi  et al.,  1971; Morgan,  1976; 
Hiller and Weber,  1985) where it is enwrapped by a mem- 
brane cisterna.  The available data argue that this enwrapped 
form of the virus loses the outermost of its two newly ac- 
quired bilayers by fusing with the plasma membrane, after 
which it is released into the medium (Dales and Pogo, 1981; 
Fenner et al.,  1989). This second infectious  form of the vi- 
1.  Abbreviations  used in this paper:  EEV, extracellular  enveloped virus; 
IBV, avian infectious bronchitis virus; IEV, intracellular enveloped virus; 
IMV, intracellular mature virus; INV, intracellular naked virus; MOI, mul- 
tiplicity of infection; PDI, protein disulfide isomerase; PFU, plaque form- 
ing units; PI, postinfection;  SLO, streptolysin O; VV, vaccinia virus. 
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additional  polypeptides  when  compared  with  the  INV 
(Payne, 1978) and is important for the dissemination of vac- 
cinia both in cell culture and in the host animal (Payne, 1980; 
Payne  and  Kristensson,  1985;  Blasco  and  Moss,  1991, 
1992). 
A  number of studies on vaccinia assembly (Dales  and 
Mossbach,  1968;  Dales and Pogo,  1981; Petterson,  1991) 
have given rise to the model that the viral particles obtain 
their first membranes by a process involving de novo mem- 
brane  biogenesis  (see  Palade,  1983).  If true,  this would 
markedly differ from both cellular membranes, which are 
thought to be synthesized on a template organelle, predomi- 
nantly the ER (Palade, 1983; Dawidowicz, 1987; Bishop and 
Bell, 1988), as well as from other enveloped viruses which 
acquire their membranes from cellular organelles (Stephens 
and Compans, 1988; Petterson, 1991; Griffiths and Rottier, 
1992). Evidence for the de novo biogenesis model is derived 
largely  from  conventional  electron  microscopic  studies 
which show the ends of the forming crescent-shaped viral 
membranes to be without obvious continuity to any cellular 
organelles (Dales and Mossbach,  1968;  Nagayama et al., 
1970).  Although a precise model has not been put forward 
for the de novo mechanism, a basic assumption has been that 
the viral membrane proteins and cellular lipids are assem- 
bled into a lipid bilayer by vaccinia encoded enzymes (Stem 
and Dales,  1974;  Stern and Dales,  1976). 
Studies on vaccinia virus assembly have so far relied on 
classical electron microscopic techniques using plastic em- 
bedded samples. To examine vaccinia virus assembly, and in 
particular the derivation of the viral membranes of the INV, 
we have made an immunocytochemical analysis of vaccinia- 
infected tissue culture cells. We have used thawed cryosec- 
tions to examine the ultrastructure of the vaccinia particles 
and to  perform immunolocalization at the ultrastructural 
level (Tokuyasu, 1973, 1980).  Thawed cryosections of fixed 
cells, as well as of gradient purified virions, showed that the 
INV form of vaccinia virus contains two, and the EEV form 
three membranes. We have used antibodies to several marker 
proteins of subceUular compartments and compared their lo- 
calization with that of the assembling viral particles.  Our 
data suggest that vaccinia virus uses a unique assembly path- 
way. Unlike other enveloped viruses which acquire a single 
membrane by budding into a cellular organelle, vaccinia vi- 
rus becomes enwrapped by a membrane cistema thereby ac- 
quiring two membranes simultaneously and remaining free 
in the cytoplasm. This membrane cisterna does not originate 
de novo but rather is derived from the intermediate compart- 
ment between the ER and the Golgi stacks. 
Materials and Methods 
Cell Culture and Virus Preparation 
HeLa and RKI3 cells were grown in MEM supplemented with 10%  FCS 
(heat inactivated) and nonessential amino acids, BHK-21 cells in Glasgow's 
minimum essential medium (G-MEM) supplemented with 5%  FCS and 
10% tryptose phosphate broth, and J774 mouse macrophages in DME sup- 
plemented with 10% FCS. All media contained 100 U/ml penicillin, 100 
ttg/ml streptomycin and 2 mM glutamine. The cell lines were grown as ad- 
herent cultures in a 5% C(h incubator at 37"C. All tissue culture reagents 
were obtained from Gibco, GIBCO BRL (Gaithersburg, MD). In this study 
we used the wild-type vaccinia virus strain W-WR and the wild-type vac- 
cinia virus strain VV-IHD-J and a recombinant vaccinia virus which ex- 
presses the E1  glycoprotein of avian infectious bronchitis virus,  VV-E1 
(Machamer and Rose,  1987).  Virus propagation and titration were per- 
formed as previously described (Earl and Moss, 1991). INV and EEV were 
purified from IHD-J infected RKI3 cells and separated from each other by 
cesium chloride or sucrose density gradients as previously described (Doms 
et al.,  1990). 
Virus Infection and Drug Treatments 
Cells were grown to 80% confluency for 2 d before infection on coverslips 
for immunofluorescence or in plastic tissue culture dishes for EM. Cells 
were infected in serum-free media at a multiplicity of infection (MOI) of 
10 plaque forming units per cell (PFU/cell). After 1 h at 370C with intermit- 
tent agitation, the inocnium was aspirated off, the cells were washed with 
PBS and placed in complete growth media at 37"C with or without rifampi- 
cin (fired 0.1 mg/ml; Sigma Immunochemicals, St. Louis, MO). Rifampicin 
was stored as a  1,000-fold  stock solution in DMSO at  -20"C. For chase 
experiments, the cells were washed three times with ice cold PBS at the indi- 
cated times and then further incubated with drug-free medium at 37"C. Cy- 
cloheximide was used at 20/~g/ml when indicated. 
HeLa and BHK cells grown on coverslips for light microscopy were in- 
fected with VV-WR at 1, 5,  10, and 20 PFU/celI, fixed at 2 h intervals up 
to 12 h postinfection (PI) and viral DNA replication was monitored using 
a  fluorescent DNA stain (see below). A  synchronous infection with low 
cytopathic effects at 8 h PI was achieved by infecting with 10 PFU/eeil. For 
EM (see below) HeLa cells were infected with W-WR at a  MOI of 10 
PFU/cell and fixed at 2-h intervals up to  12 h  PI. At 6  h  PI,  immature 
viruses were already formed in some of the cells. At 8 h PI, ,o50% of the 
cells within one section showed all the different viral structures, very often 
within one cell. Most experiments described in this study were therefore 
carried out with cells infected with 10 PFU/cell for 8 h PI, as all viral struc- 
tures, characterized by EM, had already formed whereas cytopathic effects 
were minimal. 
Antibodies 
Table I shows a list of all antigenic markers used in this study. All the anti- 
bodies we used against cellular marker proteins have been characterized 
previously (see Table I for references). The t~-DNA IgM was obtained from 
Table L Antigenic Markers 










Ac-30-10 (mouse mAb, IgM) 
Polyclonal rabbit serum 
Polyclonal rabbit serum (affinity purified) 
Rabbit ct-peptide serum a-C-terminus 
1D3  (mouse mAb, IgG) 
Rabbit ct-peptide serum1 a-C-terminus (affinity purified) 
Rabbit t~-fusion protein (affinity purified) 
G1/93  (mouse mAb, IgG) 
Rabbit polyelonal serum (affinity purified) 
Rabbit t~-peptide serum1 a-C-terminus (affinity purified) 
Hausmann et al.,  1986 
Burke et al.,  1982 
Roth and Berger,  1982 
Prehn et al.,  1990 
Tooze et al., "1989 
Chavrier et al.,  1990 
Schweizer et al.,  1988 
Saraste et al.,  1987 
Machamer and Rose,  1987 
The Journal  of Cell Biology,  Volume 121, 1993  522 Boehringer Marmheim GmbH (Mannheim, Germany), the other antibodies 
were gifts from the following sources: B. Burke (Harvard University, Cam- 
bridge, MA; cx-mannosidase II), E. Berger (University of Ziirich, Switzer- 
land; ¢x-galactosyltransferase),  S. Prehn and T. Rapoport (Max-Delbriick 
Institute, Germany; ¢x-ERp34),  P. Buck and S. Fuller (EMBL, Germany; 
c¢-PDI),  M. Zerial (EMBL, Heidelberg, Germany; c~-rab2), H.  P. Hauri 
(Biozentrum, Switzerland; or-p53),  and J.  Saraste (University of Bergen, 
Norway; c~-p58). All secondary antibodies, rhodamine or FITC coupled 
goat anti-rabbit IgG, goat anti-mouse IgG or goat anti-mouse IgM for im- 
munofluorescence and rabbit anti-mouse IgG, rabbit anti-mouse IgM, or 
rabbit anti-rat IgG for immuncelectron microscopy, were obtained from 
Organon Technika/Cappel (West Chester, PA). 
Light Microscopy 
In in vivo labeling experiments, the trans-Golgi/trans-Golgi  network was 
labeled as described (Kobayashi and Pagano,  1989) using fluorescent C6- 
NBD-ceramide kindly provided by T. Kobayashi, Tohoku University, Japan. 
All incubations for immunofluorescence labelings were carried out in PBS, 
pH 7.4, at room temperature. Infected BHK or HeLa cells were fixed after 
the indicated times with 3 % paraformaldehyde for 20 rain. After washing 
with PBS, remaining fixative was quenched with 50 mM NI-I4C1 for 10 
min. Cells were permeabilized with 0.2% Triton X-100 for 4 rain, washed 
again, transferred to 0.2% gelatine, and then labeled with the primary anti- 
body in 0.2% gelatine for 20 rain. The coverslips were rinsed three times 
for 5 rain and incubated with fluorescently labeled secondary antibodies in 
0.2 % gelatine for 20 rain. For double-labeling experiments, the two primary 
and the two secondary antibodies were applied together. For localizing 
rab2, the cells were permeabilized with 0.5% saponin in 80 mM K-Pipes, 
pH 6.8, 5 mM EGTA,  1 mM MgCI2 for 5 min before fixation to wash out 
cytosolic, nonmembrane-bound  protein. The labelings were essentially per- 
formed as described (Chavrier et ai.,  1990). 
Nuclear and viral DNA were visualized by staining with 5 t-~g/mi bis- 
benzimide (Hoechst No.  33258  for fixed cells and membrane permeable 
Hoechst No. 33342  for living cells; Sigma Immunochemicais) for 5 rain. 
After extensive washing in PBS the coverslips were mounted on glass slides 
using moviol as mounting medium and examined with an Axiophot fluores- 
cence microscope (Carl Zeiss, Inc., Oberkochen, Germany). 
Electron Microscopy 
Vaccinia-infected BHK  or  HeLa  cells  were  fixed  for  60  min  in  1% 
glutaraldehyde in 0.2 M cacodylate buffer, pH 7.4, stained with 1% OsO4, 
1.5%  K3Fe(CN)6  followed by  1%  magnesium uranylacetate for 60 min, 
respectively, and processed for conventional Epon embedding. All incuba- 
tions were carried out at room temperature. For immunoelectron micros- 
copy infected cells were removed from the tissue culture dish by treating 
them with proteinase K (25 tzg/ml for HeLa and 50/~g/mi for BHK; Merck, 
Darmstadt, Germany) on ice for 2-3 min or with 10 mM EDTA on ice for 
45 min for J774 mouse macrophage cells. Purified INV and EEV bands 
were collected from sucrose gradients by hand. All cell and virus samples 
were prefixed with 1.5 % paraformaldehyde (PFA) in 0.25 M Hepes, pH 7.4, 
spun at 800 g, fixed in 8% PFA in 0.25  M  Hepes, pH 7.4 overnight and 
spun at 10,000 g for 15 min. The pellets were infiltrated with 2.1 M sucrose 
as cryoprotectant in PBS for 3  x  10 rain and frozen in liquid nitrogen. 
Ultrathin sections were cut at  -90°C and transferred to formvar coated 
EM-grids. The immunolabelings as well as the drying and contrasting of 
the sections were performed as described (GritTiths et al., 1983,  1984).  For 
quantitation, electron micrographs were taken in a systematic fashion at a 
primary magnification of 10,000 and the density of gold labeling with p58 
over  virions,  nucleus  and  cytoplasmic  areas  around  the  virions  was 
quantified by point counting (Grifliths and Hoppeler, 1986). 
Experiments Using  Permeabilized Cells 
Adherent HeLa cells were infected with VV-WR at a MO[ of I0 PFU/cell 
either without or with rifampicin followed by a  l-h chase. 
For the streptolysin O (SLO) permeabilization, at 15 h PI the cells were 
transferred onto ice, washed 3×  with ice cold SLO-buffer (250 mM su- 
crose, 5 mM magnesium acetate, 50 mM potassium acetate, 25 mM Hepes, 
pH 7.4,  I mM DTT) and then incubated on ice with 4 U/ml SLO (Wellcome 
Diagnostics, England) in SLO-buffer (0.5  ml/30 mm dish) for I0 rain to 
bind the SLO to the plasma membrane. The cells were washed again 3 × 
with ice cold SLO-buffer, incubated at 37°C for 15 min to allow pore forma- 
tion of the SLO and transferred back onto ice.  Under these conditions 
50-70 % of the cellular lactate dehydrogenase is released into the medium. 
For the preparation of broken cells, at 8 h  P1 the ceils were carefully 
scraped into the media and colfecwxl by pelleting (5 inin, 1,000 g). All sub- 
sequent steps were carried out at 4°C. The infected cells were washed once 
with PBS, resuspended in 0.2 ml/100 mm dish breaking buffer (0.25 M su- 
crose,  3  mM imidazole, pH 7.4)  and gently broken by pipetting twice 
through a small, yellow pipette tip (Gilson Medical Elec. Inc., Middleton, 
Wl) to selectively perforate the plasma membrane. Under these conditions, 
,~50-70% of the cells were broken as judged by trypan blue staining and 
most, if not all, of the broken cells retained their major cytoplasmic or- 
ganelles including the viral factories. The broken cells were pooled (5 rain, 
3,000 g) and resuspended in 0.6 ml incubation buffer (0.25  M sucrose, 25 
mM Hepes, pH 7.4, 5 mM magnesium acetate, 50 mM potassium acetate) 
containing 6 nm BSA-gold (final OD 20) for 45 rain or containing proteinase 
K (Merck, Darmstadt, Germany; 0.3 mg/ml) for 5 rain followed by PMSF 
(final 0.3 mg/ml) for 5 min. 
The SLO-permeabilized or broken cells were fixed with 1% glutaraide- 
hyde in 0.2 M cacodylate buffer, pH 7.4,  for 1 h and processed for Epon 
embedding. 
Phospholipid Analysis of  Gradient-Purified 
INV and EEV 
A subconfluent 75-cm  2 flask of RK13 cells was incubated for 24 h in low- 
phosphate medium containing 3 mCi 32po4 (New England Nuclear, Bad 
Homburg, Germany) without serum (van Meer and Simons, 1982) to label 
the cellular phospholipids. The cells were then infected with IHD-J at 10 
PFU/cell by addition of the virus and 5%  FCS directly to the labeling 
medium. After 24 h INV and EEV were harvested from the cells and the 
medium, and purified on cesium chloride gradients (Donas  et al.,  1990). 
The gradients were fractionated and the radioactivity peaks were pooled. 
For [14C] labeling 125/~Ci of [2-14C]acetate  was added to the cells at the 
time of infection, which lasted for 30 h. Lipids were extracted and analyzed 
by two-dimensional high performance thin layer chromatography as de- 
scribed before (van Meer and Simons, 1982),  except that the radioactive 
spots on the plates were localized both by autoradiography and colocaiiza- 
tion with the unlabeled carrier lipid after iodine staining. All samples were 
analyzed in duplicate. The data in Table U are expressed as the mean + 
the standard error of the mean. 
Table II. Phospholipid Composition of Gradient-Purified INV and EEV 
1. experiment:  32p 
Percent of total label 
Phospholipid  INV  EEV 
2.  experiment:  '4C 
Whole cells  INV  EEV 
Sphingomyelin  5.7  +  0.8  13.4  +  1.3  9.8  +  0.4  3.7  +  0.3  15  +  0.1 
Phosphatidylserine  3.7  +  0.2  9.5  +  0.1  5.8  +  0.4  1.7  +  0.5  4.6  +  0.3 
Phosphatidylcholine  36.0  +  1.7  29.8  +  1.6  42.8  +  1.2  41.2  +  1.6  47.8  +  0.5 
Phosphatidylinositol  15.2  +  1.5  5.8  +  0.2  7.0  +  0.5  11.5  +  1.2  6.5  +  0.9 
Phosphatidylethanolamine  25.6  +  0.2  33.9  +  0.6  35.8  +  1.5  6.2  +  0.1  23.1  +  0.6 
"acyl-bis(monoacyiglyceryl) phosphate"  11.9  +  1.0  7.6  +  0.2  0.8  +  0.1  35.9  +  1.4  2.9  +  0.1 
Sodeik et al. Assembly of Vaccinia Virus  523 Figure 1. Localization of the viral factories. Cryosection of a VV-WR infected HeLa cell at 8 h after infection labeled with anti-DNA and 
protein A-gold.  The apparent cytoplasmic labeling for DNA identifies the site of viral DNA replication: the viral factory. These viral 
factories include the regions of  viral assembly in which the viral crescents (CR) and some of  the spherical immature virions (/V) are located. 
The brick-shaped mature intracellular naked virions (INV) and the intracellular enveloped virions (IEV)  are concentrated in the Golgi region 
of the cell. Note that the DNA within the nucleus (N) is labeled whereas the Golgi complex (G) is not labeled. DNA could also be detected 
within the virions (white arrows). The inset shows an INV in which the DNA is labeled (white arrows). Bar, 200 nm. 
Results 
Localization of Viral Factories Using DNA markers 
Vaccinia virus replication and assembly occur in discrete cy- 
toplasmic structures, termed viral factories (Moss,  1990). 
Since well-characterized marker proteins  for these  struc- 
tures  have  not been described,  we  identified them  using 
markers for DNA (Esteban,  1977).  With bis-benzimide, a 
fluorescent DNA stain, we detected 2-5 viral factories per 
cell at 4  h  PI which coalesced into one or two large, jux- 
tanuclear factories at 8 h  PI.  For EM,  cryosections of in- 
fected HeLa cells were labelled with the anti-DNA antibody 
(Hausmann et al.,  1986). Both the nuclei and cytoplasmic 
areas which contained crescent shaped membranes as well 
as discrete immature virions (Fig.  1) were decorated with 
protein A-gold. The DNA within the virions could also be 
labeled (Fig.  1, arrows). However, the cytoplasmic areas la- 
beled by the anti-DNA antibody were much larger than the 
areas where viral crescents were formed. Additionally, the 
crescents as well as most of the IV themselves were not la- 
beled for DNA. We conclude that only parts of the cytoplas- 
mic fluorescence seen after staining with the DNA stain cor- 
responded  to  the  cytoplasmic assembly  sites  of vaccinia 
virus observed by EM. 
Assembly of Vaccinia Virus Particles 
The  first  distinctive  structures  of  assembling  virus  are 
crescent-shaped membranes located within the viral facto- 
ries which show a brush-like array of electron-dense spicules 
on their convex surface (Dales and Mossbach,  1968). Close 
inspection reveals membranous structures in close proximity 
(Fig. 2 a), or even continuity (Fig. 2 e), with the crescents. 
The membranes within the viral factories were better visual- 
ized in cryosections which also revealed that within the cres- 
cent, a second membrane could often be detected (Fig. 2, b 
and g). In epon sections of infected cells the two membranes 
were difficult to resolve (see Topology of Virus Assembly, 
below). Occasionally however, at the ends of the crescents 
two membranes could be resolved (Fig. 2 d) as well as mem- 
brane loops connecting the two bilayers (Fig. 2 c). The cres- 
cents  further  assemble  into  spherical,  immature  virions 
which also have electron-dense spicules in their membranes 
(Nagayama et al., 1970; Morgan, 1976). Many images from 
very thin Epon- or cryosections suggested that there are two 
membranes within the immature virions (Fig. 2 f). Further, 
a  small  subpopulation of immature virions  showed a  dis- 
tinct inner membrane that was separated from the outer one 
(Fig. 2, g and h). It seems likely that these are intermediate 
forms between immature virions and the next stage of viral 
assembly, the brick- or ellipsoid-shaped INV.  Cryosections 
showed two distinct membranes within the INV (Fig. 2, i,j). 
Between the two membranes of the INV a regular spike-like 
array was usually evident but whether these are identical to 
the spicules of the immature virions is unclear. 
After their formation, some of the INV particles become 
enwrapped by a cellular membrane cisterna (Ichihashi et al., 
1971; Morgan, 1976;  Hiller and Weber, 1985), thus acquir- 
ing their third and fourth membranes simultaneously.  We 
will refer to the resulting four-membraned viral form as the 
intracellular  enveloped  virus  (IEV).  In  cryosections,  we 
could easily identify viral particles which had four distinct 
membranes (Fig. 3, c-e), whereas in Epon sections the in- 
nermost membranes could not be clearly visualized (Fig. 3, 
The Journal of Cell Biology, Volume 121,  1993  524 Figure 2.  Assembly of vaccinia virus from viral crescents to immature virions and maturation to the intracellular naked  virions, a, c, 
e, and fshow ultrathin Epon sections while b, d, and g-j are thawed  cryosections of VV-WR infected BHK (a)  or HeLa cells (b-j) at 
8 h after infection. In c the cells have been permeabilized using streptolysin O (see Materials and Methods and Fig. 5) to increase the 
membrane contrast. The membranous structures within the viral factories are routinely better preserved in thawed cryosections (arrowheads 
in b) than in Epon sections (arrowheads in a). a-f show assembling virions, the crescents (CR), of which the membranes are in continuity 
with other membranes (arrowheads in b-e). The crescents mature into the spherical immature virions (/V in a  and b).  The arrows  in b 
and the arrowheads infpoint to double membrane profiles of viral crescents.  The two membrane profiles are usually not visible over the 
whole surface of the crescents or the immature virions (a-f). The crescents as well as the immature virions have spikes on their convex 
surface (arrows in c and d).  Two membranes (arrows in g and h) become evident during the transition from the immature virus to the 
intracellular naked  virions and in the mature intracellular naked  virus (IN~, arrows in i and j). Bars,  200 nm. 
Sodeik et al. Assembly of Vaccinia Virus  525 Figure 3. Acquisition of a membrane cisterna by the intracellular  naked virus to form the intracellular  enveloped virus, a and b show ultra- 
thin Epon sections  while c-e are thawed cryosections of VV-WR infected HeLa cells at 8 h after infection, f  is a cryosection of gradient- 
purified  intracellular  naked virus (/NV).  Some of the INVs become enveloped  by a membrane cisterna (arrows in c) thereby maturing 
into the intracellular  enveloped virus (IEV). Whereas the two innermost membranes of the intracellular  enveloped virus (IEV) are often 
not visible  in Epon sections  (a and b) the membrane cisterna forming the two outermost membranes of the IEV are evident  (arrows in 
a and b). In thawed cryosections, the four membranes of  the IEV can be resolved; the arrows (c, d, and e) indicate the outer two membranes. 
Cryosections of gradient purified  INV particles (f) reveal two membranes (small arrows) within all particles.  M, mitochondrium. Bars, 
200 rim. 
a  and b).  The outer envelope of the IEV is thought to fuse 
with the plasma membrane, thereby releasing the EEV into 
the medium (Morgan,  1976; Payne and Kristensson,  1979). 
Cryosections of sucrose gradient-purified virions showed 
the  same morphology, namely two membranes  within the 
INV (Fig.  3 f)  and three within the EEV (not shown).  In 
summary, the cryosections revealed an additional membrane 
within all viral particles which were poorly resolved in Epon 
sections,  namely two membranes  in the  immature  virions 
and the INV, four membranes  in the IEV and three mem- 
branes  in the EEV. 
Synchronization  of Viral Assembly with Rifampicin 
To characterize virus assembly in more detail,  we used the 
The Journal of Cell Biology, Volume 121, 1993  526 Figure 4. Rifampicin bodies. Phase-contrast microscopy (a and b). VV-WR infected HeLa cells were fixed at 8 h after infection. The ceils 
were incubated without (a) or with (b) rifampicin during the whole infection. In the cells treated with rifampicin, many rifampicin bodies 
can easily be identified due to their strong phase contrast (arrows  in b). Electron microscopy (c and d). Epon sections of rifampicin-treated 
VV-WR BHK cells at 10 h after infection contain many inclusion bodies, termed rifarnpicin bodies (R), which are surrounded by irregularly 
shaped membranes. Occasionally, membrane cisternae (arrowheads in d) adjoin the fifampicin bodies. Bars: (a and b) 20 gin;  (c and 
d) 200 rim. 
antibiotic rifampicin to synchronize the assembly process. 
Rifampicin reversibly blocks the virus assembly without in- 
terfering with viral DNA  replication or protein synthesis 
(Moss et al., 1969). It leads to the accumulation of rifampi- 
cin bodies, which are large, electron-dense structures sur- 
rounded by  irregularly  shaped  smooth  membranes.  Bio- 
chemical  studies  have  shown  that  the  rifarnpicin  bodies 
contain  several  vaccinia  structural  proteins  (Payne  and 
Kristensson,  1990).  Infected BHK or HeLa cells were in- 
cubated in the presence of rifampicin and then placed in 
drug-free media for various times before fixation at 8 h PI. 
When there was  no chase-period,  rifampicin bodies were 
easily  detected by light  microscopy using  phase-contrast 
(Fig. 4, a  and b). Electron micrographs showed that these 
structures were partially surrounded by irregularly shaped, 
smooth membranes (Fig. 4, c and d). 
Upon removal of rifampicin viral assembly proceeds as 
normal (Moss et al.,  1969). Crescent-shaped buds arose in 
a  synchronized way  from most  of the  rifampicin bodies 
within 5  min;  after 1 h  chase spherical immature virions 
were enriched, and after 2 h chase INVs had appeared (not 
shown). These observations support previous studies which 
proposed that the rifampicin bodies contain the precursors 
of  the vaccinia membranes (Grimley et al., 1970; Nagayama 
et al.,  1970). Therefore, we used dfampicin in order to ac- 
cumulate vaecinia precursor membranes and to synchronize 
virus assembly in infected cells. 
Topology of Virus Assembly 
Our EM studies were not consistent with the current model 
of vaccinia assembly (Dales and Mosshach, 1968; Dales and 
Pogo, 1981; Palade, 1983; Petterson, 1991) for two reasons. 
First, the de novo model does not account for the continuity 
of assembling virions with cellular membranes and second, 
it does not explain the acquisition of the two membranes of 
the INV. We could think of  two alternative hypotheses which 
would be consistent with our data.  The first would be that 
the virus buds into a cellular compartment, thereby acquir- 
ing its first membrane and forming the immature virus. Sub- 
Sodeik et al. Assembly of Vaccinia Virus  527 Figure 5. The viral crescents are continuous with cisternal and tubular membranes.  Epon sections (a-e) of VV-WR infected HeLa cells 
in which the plasma membrane has been permeabilized 12 h after infection using the bacterial toxin streptolysin O (SLO) to deplete cyto- 
plasmic components and leading to an increase in membrane contrast.  Under these conditions the membrane continuities between the 
membranes oftbe viral crescents and cisternal and tubular cellular membranes become evident. In a, two tubules (small  arrowheads) appear 
to emanate from an electron-dense membrane structure that itself is continuous (large arrowhead) with the characteristic round profile 
of a viral crescent.  The large arrows (a and c) indicate continuities between the RER and membrane tubules.  A  ribosome on the RER 
is indicated (small arrow in a  and c). The arrowheads in b-e point to continuities between the viral crescents and cellular membranes. 
The small double arrows (c) indicate a forming crescent where the two membranes are distinct and in continuity (large arrowhead) with 
other membranes, d and e show continuities between viral crescents and membrane tubules. These tubules, which have a diameter of,'o 30 
nm,  are also seen in untreated cells but are much better visible in SLO-permeabilized cells. Bars,  200 rim. 
The Journal of Cell Biology, Volume 121, 1993  528 Figure 6. Labeling of the cytoplasmic site of intracellular  membranes in VV-WR infected cells.  Ultrathin  epon sections  (a-e). At 8 h after 
infection with VV-WR HeLa cells were transferred  onto ice, gently broken by homogenization to selectively perforate the plasma membrane, 
and incubated on ice with BSA-gold (a and b) or proteinase  K (c-e). BSA gold has ready access to the cytoplasm as well as to the immature 
virions (asterisk in a) and to both sides of the crescent shaped membranes (a). In contrast, gold particles are excluded  from the lumen 
of all identifiable  cellular organdies, including  the nuclear envelope and the ER (arrowheads in a). A small fraction of immature virions 
do not contain BSA gold (star in a). BSA gold also has access to the space between the INV and the wrapping membranes but not the 
lumen of this cisternae (b).  Proteinase K (c-e) leads to a dramatic change in the morphology of some of the immature virions (asterisks 
in c-e).  These immature virions appear empty and two membranes with a trilarninar  appearance (arrowheads in c-e) become visible. 
The content of some immature virions remains (star in e) and in these virions the morphology of the membranes has not changed; we 
assume that only these virions are fully closed particles.  In these particles the two membranes cannot be visualized.  N, nucleus.  Bars, 
200 nm. 
sequently it buds out of this organelle, thus obtaining its sec- 
ond  membrane  and  forming  the  INV.  By  this  assembly 
mechanism the immature virions would contain one mem- 
brane and would be localized within the lumen of that or- 
ganelle.  Alternatively,  the  virus  could  acquire  two  mem- 
branes  within  a  single  step  by  becoming enveloped  by  a 
membrane cisterna.  Such a  mechanism would predict that 
the immature virions should contain two membranes and be 
free in the cytoplasm rather than in the lumen of a cellular 
organelle. 
To obtain a better membrane visualization, infected HeLa 
cells were permeabilized at 15 h PI using the bacterial toxin 
SLO (Bhakdi  and Tranum-Jensen,  1983;  Ahnert-Hilger  et 
al.,  1989).  The cells were treated with rifampicin and then 
chased for 1 h to accumulate viral crescents prior to the SLO 
treatment and embedding in Epon. The permeabilization led 
to a  significant extraction of cytoplasmic proteins  such as 
lactate dehydrogenase, which increased the membrane con- 
trast and allowed a better visualization of membrane tubules. 
Under  these  conditions  the  continuities  between  the  viral 
crescents  and  cytoplasmic  membranes  became  obvious. 
Specifically, the viral crescents appeared to be continuous ei- 
ther with double membrane cisternae or with distinct tubular 
elements (Fig.  5).  These tubules,  which have a uniform di- 
ameter of ~  30 nm, are thinner than the average thickness 
of our thin sections and are difficult to visualize in nonex- 
tracted cells. In the SLO extracted cells it is also evident that 
at least some of these tubules are continuous with the rough 
ER (Fig.  5  a). 
In most cases it was difficult to resolve two membranes 
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(Fig.  5  c), images were obtained which show clearly that 
these structures also consist of two distinct bilayers. Such 
images  lead  us  to  propose that these  cisternal  structures 
would be organized with the same topology as ER or Golgi 
membranes with the space between the two bilayers repre- 
senting an ecto-cytoplasmic compartment. In the next series 
of experiments we addressed this issue using an electron- 
dense marker for the cytoplasm. 
Infected HeLa cells were gently broken to selectively per- 
forate the plasma membrane, and incubated at 4"C with BSA 
gold.  Under these conditions, "~50-70%  of the cells were 
broken as judged by trypan blue staining and EM analysis 
showed that most of  these cells retained their major cytoplas- 
mic organelles and the viral factories. BSA gold had free ac- 
cess to the cytoplasm, to both sides of the crescent shaped 
membranes and to most of the immature virions (Fig. 6 a). 
A small percentage of  the immature virions had no BSA gold 
in their centres (Fig. 6 a, asterisk), arguing that these parti- 
cles had already completely sealed. Gold particles were ex- 
cluded from the lumen of all identifiable cellular organelles, 
the nuclear envelope, rough ER (Fig. 6 a), the Golgi com- 
plex and mitochondria (not shown). BSA gold also had ac- 
cess to the space between the INV and the wrapping mem- 
branes, but not to the lumen of this cisterna (Fig. 6 b). Since 
these experiments argue that the assembling virions are not 
within a  cellular organelle but free in the cytoplasm they 
should be accessible to proteolytic digestion in broken cells. 
When the broken ceils were treated with proteinase K on ice 
for 5 min, in a subset of these cells the assembling virions 
showed dramatic changes in their morphology, namely two 
membranes became clearly visible (Fig. 6, c-e). In addition, 
the contents of these virions had been completely removed. 
In agreement with the BSA-gold data, in a small percentage 
of  the spherical immature virus profiles the appearance of  the 
viroplasm was not affected by the protease treatment (Fig. 
6e). 
These experiments confirm that the immature virions con- 
tain two membranes, consistent with their being wrapped by 
a membrane cisterna. In addition, only a small percentage 
of the  immature  virions  found at  steady  state were fully 
sealed since the contents of the majority were susceptible to 
both BSA-gold and protease digestion. 
Relationship of Viral Factories to Cellular OrganeUes 
We used a series of  characterized markers for different cellu- 
lar compartments to determine if the membranes continuous 
with the viral crescents belong to a cellular organdie or to 
a new membrane system devoid of cellular proteins and in- 
duced by the vaccinia infection. We found that HRP internal- 
ized during the last 2 h of infection as well as a spectrum of 
antibodies specific for endocytic organdies did not colocal- 
ize with the viral factories (Schmelz, M.,  B.  Sodeik, M. 
Ericsson, G. Hiller, H. Shida, E. Wolffe, and G. Grifliths, 
manuscript in preparation). Since the viral factories were al- 
ways located in the perinuclear region of the cell, we inves- 
tigated if markers for the Golgi complex would label them. 
Antisera to either mannosidase  II,  a  135-kD cis-medial- 
Golgi marker protein (Burke et al., 1982; Baron and Garoff, 
1990),  or galactosyltransferase, a  trans-Golgi marker en- 
zyme (Roth and Berger, 1982), in combination with DNA- 
staining,  showed that the viral factories did not colocalize 
Figure 7. Immunofluorescence  microscopy of  a cellular marker pro- 
tein for the Golgi complex in vaccinia infected ceils. VV-WR in- 
fected HeLa cells were fixed at 8 h after infection, permeabilized, 
and  labeled  with  anti-galactosyltransferase  (a)  followed by  a 
rhodamine-conjugated  goat anti-rabbit antibody, b shows the corre- 
sponding DNA staining using a fluorescent DNA dye. The labeling 
for galactosyltransferase (a; the white dotted lines indicate corre- 
sponding regions in b) does not colocalize with the viral factories 
as identified by cytoplasmic DNA staining (b). N, nucleus. Bar, 
10 #m. 
with these markers (Fig. 7, a and b). We made the same ob- 
servations using  fluorescent Ct-NBD-ceramide,  a  specific 
marker of trans-Golgi/TGN elements (Lipsky and Pagano, 
1983,  1985;  not  shown).  Since  viral  factories  did  not 
colocalize with  markers  of endosomes,  lysosomes,  Golgi 
stacks or TGN, we conclude that the membranes of the im- 
mature virions are not derived from these organelles. 
To  visualize  the  ER,  we  used  antibodies  to  protein 
disulfide isomerase (PDI; Tooze et al.,  1989), a soluble ER 
protein, and to ER-p34, a 34-kD integral membrane protein 
of the rough ER (Prehn et al., 1990). Fluorescence labeling 
experiments using anti-PDI (Fig. 8, a  and b) or anti-ER-p34 
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teins for the endoplasmic reticulum in vaceinia infected cells. VV- 
WR infected HeLa ceils were labeled with anti-PDI (a) followed 
by a rhodamine-conjugated  goat anti-mouse antibody or with anti- 
ER-p34 (c) followed by a rhodamine-conjugated  goat anti-rabbit 
antibody, b and d show the corresponding DNA staining as de- 
scribed in Fig. 7. In infected  cells labeling for both PDI (a) and SSR 
(c) show a fluorescence  pattern as expected for the rough ER. Note 
that the labeling is significantly  lower in the regions of  the viral fac- 
tories as defined by cytoplasmic DNA staining (arrowheads in b 
and c). N, nucleus. Bars, 10/an. 
(Fig. 8, c and d) showed a reticular staining as expected for 
the  ER.  However,  the  ER  signal  was  diminished in  the 
regions of the viral factories. Since we could not determine 
by light microscopy whether this labeling corresponded to 
the ER surrounding the viral factories or to ER membranes 
extending into the viral factories, PDI was localized by im- 
munoelectron microscopy. The crescents as well as the im- 
mature (Fig. 9, a-c) and mature virions (not shown) were 
completely devoid of labeling. However,  the membranes in 
continuity with the viral crescents were labeled, though less 
strongly than the ER cisternae (Fig. 9 b). PDI labeling was 
consistently found in close vicinity to the Golgi stacks and 
often extended to one cisterna on one side of  the stack in both 
vaccinia  infected  (Fig.  9  d)  and  noninfected  cells  (G. 
Grifliths, unpublished data).  Similar results were seen in 
cells infected with vesicular stomatitis virus (Pepperkok, R., 
J.  Scheel,  H.  Horstmann, H.  P.  Hauri,  G.  Griffiths, and 
T. E. Kreis, manuscript submitted for publication) as well 
as in cells infected with mouse hepatitis virus (Krijnse-Locker, 
J., M.  Ericsson, P. J.  M.  Rottier, and G. Grifliths, manu- 
script in preparation).  In rifampicin treated samples, there 
was some labeling associated with the vaccinia precursor 
membranes adjoining the rifampicin bodies; however this 
was significantly lower than the labeling seen over the ER 
(Fig. 9, e and  f) and the nuclear envelope (not shown). These 
experiments implied that the vaccinia membranes might be 
derived from a cellular compartment related to the ER. 
Markers for the Intermediate Compariment 
between the ER and the Golgi Stacks Colocalize 
with the Viral Factories 
Recently a number of marker proteins have been described 
which localize specifically to an intermediate station of the 
biosynthetic pathway which has been referred to as the inter- 
mediate compartment, the salvage compartment or the cis- 
Golgi  network (reviewed in  Hauri  and  Schweizer,  1992; 
Mellman  and  Simons,  1992;  Rothman  and  Orci,  1992; 
Saraste and Kuismanen, 1992).  Here, we will refer to this 
compartment as the intermediate compartment. Until now 
three cellular markers have been shown to be especially en- 
riched in this organelle: rab2, a small GTP-binding protein 
(Chavrier et al.,  1990),  as well as two integral membrane 
proteins of unknown function, p53 (Schweizer et al.,  1988, 
1990)  and p58 (Saraste et al.,  1987). 
We used antibodies to these proteins to localize the inter- 
mediate compartment in vaccinia infected BHK, HeLa or 
J774  macrophage cells.  Immunofluorescence experiments 
using an antibody to p53 showed that there was weak label- 
ing in some regions of the viral factories as defined by DNA 
staining, as well as more extensive labeling in the areas ad- 
joining the viral factories (Fig.  10, a  and b). Four different 
affinity-purified rabbit antibodies against rab2 were tested: 
two polyclonal sera raised against synthetic peptides corre- 
sponding to the COOH terminus of rab2 and two polyclonal 
sera  made against  a  bacterially expressed  fusion protein 
(Chavrier et al., 1990).  By immunofluorescence, one of the 
anti-eOOH terminus and one of the anti-fusion protein sera 
gave a viral factory (Fig.  10,  c and d) or rifampicin body 
labeling (Fig. 10,fand h), the two other sera gave a labeling 
similar to the p53 labeling. They all gave identical labeling 
patterns by immunoelectron microscopy. The labeling ob- 
tained  with the two  anti-COOH  terminus  sera  couM be 
blocked by pre-incubating the sera with the specific synthetic 
peptide (amino acid 158-176 of rab2) whereas an unspecific 
peptide (amino acid 182-197  of rab5) had no effect. Double 
immunofluorescence experiments  (not  shown)  confirmed 
that in vaccinia infected cells,  two of the four antibodies 
against rab2 do not colocalize with p53 as they do in non- 
infected cells (Chavrier et al.,  1990).  In rifampicin-treated 
infected cells, two of the four a-rab2  antibodies, and to a 
lesser extent, p53 (Fig. 10, e-h), localized to the rifampicin 
bodies which contained the vaccinia precursor membranes. 
The significance of the difference in the labeling patterns 
seen with the two classes of rab2  antibodies is presently 
unclear. To determine whether the membranes of the viral 
factories were related to the intermediate compartment, we 
performed immunogold labeling. Antisera against rab2 (Fig. 
11 a), p53 (Fig. 11 b) and p58 (Fig. 11, c and d) labeled the 
membranes in some regions of the viral factories as well as 
membranes in continuity with assembling virions (Fig.  11, 
a, c and d). With all these antibodies tubulo-vesicular ele- 
ments often extending a considerable distance from the Golgi 
stacks as well as one or two cisternae on one side of  the Golgi 
stack were labeled (Fig.  11, a  and b). 
Sodeik et al. Assembly of Vaccinia Virus  531 The Journal of Cell Biology, Volume 121,  1993  532 Figure 10. Immunotluorescence microscopy of cellular marker proteins for the intermediate compartment between the ER and the Golgi 
complex in vaccinia infected cells. VV-WR infected HeLa (a, b, and e-h) or BHK (c and d) ceils were extracted with saponin before fixation 
and labeled with anti-p53 (a and e) or anti-rab2 (c and f). b, d, and g  show the corresponding DNA staining, and h the phase-contrast 
image corresponding to e, f, and g. In infected cells, labeling for p53 results in a perinuclear pattern (a) which is located on the same 
side of the nucleus as the viral factory, as defined by cytoplasmic DNA staining (b). In contrast, rab2 (c) colocalizes to a large extent 
with the viral factories (d).  Double labeling of rifampicin-treated infected cells (e-h) shows that the bulk of the p53 labeling (e) is not 
changed by rifampicin whereas the bulk of rab2 (f) is concentrated on the rifampicin bodies, as identified  by phase contrast (h). The arrows 
(e, f, and h) point to rifampicin bodies which overlap with the labeling for p53 and rab2. The rifampicin bodies occur predominantly in 
the region of the viral factories as defined by DNA staining (g).  N, nucleus.  Bars,  10 ttm. 
We undertook a  quantitative analysis of the labeling with 
p58 by taking 20 electron micrographs in a systematic fash- 
ion and determining  the densities  of labeling over different 
structures.  Since  the  membranes of the intermediate  com- 
partment in the vicinity of the assembling virions were often 
very difficult to visualize,  we decided  to quantify  areas of 
cytoplasm within the viral factories. For comparison, we de- 
termined the amount of labeling over the virions themselves 
as well as over the nuclei.  The membranes within the viral 
factories  showed  on  average  3.05  (+0.41)  gold  parti- 
cles/#m  2,  whereas  the  virions  or the  nuclei  had  only 0.95 
(+0.5)  gold//xm  2 or 0.67 (+0.1) gold//~m  2, respectively. The 
virions and the nuclei  are not expected to contain p58 and 
we  therefore  considered  this  labeling  to  be  background. 
These data show that the labeling for p58 in the region of the 
viral factories was over three times higher than background 
values.  Since the membranes of the intermediate  compart- 
ment comprise only a fraction of the area of the viral factory 
on the micrograph that we used for quantitation,  we expect 
that these data underestimate the amount of specific labeling 
associated  with  the membranes of this  compartment. 
Colocalization of Vaccinia Membranes with the Avian 
Infectious Bronchitis Virus E1 Protein 
Since the abundance  of the cellular marker proteins  of the 
intermediate compartment is not very high,  especially dur- 
ing longer infection times when the host's protein synthesis 
is shut off, we sought a  suitable marker that is expressed at 
higher levels.  We chose a  recombinant vaccinia virus (VV- 
El) which expresses the E1 integral membrane protein of the 
avian  infectious  bronchitis  virus  (IBV  El;  Machamer  and 
Rose, 1987) under the control of the vaccinia 7.5 k promoter. 
It has been shown previously using VV-E1  that the bulk of 
the protein remains Endo H  sensitive (Machamer and Rose, 
1987) indicating that it does not reach the medial Golgi ap- 
paratus.  Under  these  conditions  IBV  E1  accumulates  in 
membrane structures closely associated with the cis-side of 
the Golgi stacks (Machamer et al.,  1990).  These results, to- 
gether  with  the  observation  that  another  coronavirus,  the 
mouse hepatitis virus, buds into a post-ER, pre-Golgi com- 
partment (Tooze et al.,  1984; Krijnse-Locker, J., M. Erics- 
son, P. J. M. Rottier, and G. Griffiths, manuscript in prepara- 
Figure 9. Immunoelectron microscopy of cellular marker proteins for the ER in vaccinia infected cells. Thawed cryosections of VV-WR 
infected BHK (a,  8 h after infection), J774 macrophages (b,  18 h after infection) or HeLa cells (c-f, 9 h after infection) were labeled 
with anti-PDI followed by protein A-9 nm gold. Cells in d-f were treated with rifampicin during the infection. Anti-PDI labeling reveals 
several ER-cisternae (ER) which occasionally extended to the viral factories (a). Occasionally, labeling for PDI is seen on a membrane 
cisterna in very close proximity to the viral crescents (CR), especially in J774 macrophages (b). In general, the membrane cisternae continu- 
ous with or in close proximity to the assembling virions are not labeled (a and c). PDI labeling is also found in close proximity to the 
Golgi stack, often extending in to one cisterna on one side of the stack (d). In rifampicin-treated cells, PDI labeling is high in ER-cisternae 
(arrows in e and f) and is present in small amounts on the membranes surrounding the rifampicin bodies. (R, arrowheads in e and f). 
CR, crescent;/E,  immature virus; R, rifampicin body; ER, endoplasmic reticulum;  (7,  Golgi complex. Bars, 200 nm. 
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a  pre-Golgi  compartment,  presumably  the  intermediate 
compartment. There are two advantages in using VV-E1. Un- 
like tab2, IBV E1 glycoprotein is an integral membrane pro- 
tein and, compared with p53 and p58, it is expressed at very 
high levels in VV-EI infected cells. 
In  immunofluorescence experiments  using  HeLa cells, 
IBV E1 colocalized with p53 in the same perinuclear region 
as v,  ell as occasionally on discrete punctate structures in the 
periphery of  the cell (Fig. 12, a and b). When compared with 
p53 (Fig.  12 b), IBV E1 (Fig.  12 a) showed less labeling in 
the peripheral parts of the cells. This restriction of the IBV 
E1 labelling was especially evident in those cells in which 
cycloheximide was present during the last 2 h of infection to 
chase as much of the IBV E1 as possible out of the ER (not 
shown). In the presence of rifampicin, the bulk of IBV E1 
also  accumulated  in  a  perinnclear location.  Additionally, 
there was a lower labeling on the rifampicin bodies which 
contain the vaccinia precursor membranes (Fig.  12, c-e). 
This experiment suggests that the vaccinia membranes are 
derived  from  membranes  containing  an  abundantly  ex- 
pressed protein which is retained in an early biosynthetic 
compartment. 
Double-immunogold labeling  experiments using VV-E1 
infected HeLa cells showed that IBV E1 colocalized to a large 
extent with p53  on the  same  smooth membranes  located 
close to both the nuclear envelope and the Golgi stacks, as 
well as on one or two cisterna on the cis-side of the Golgi 
stacks (Fig.  13 a). Strong labeling for VV-E1 was obtained 
on the smooth membranes within the viral factories which 
were in close proximity to some of the assembling virions 
(Fig.  13 b).  However, many vaccinia crescent membranes 
were continuous with membranes that were not labeled for 
this marker. We next compared the localization of IBV E1 
to p58 in vaccmia-infected cells. To accumulate viral cres- 
cent and immature virions, we used mouse macrophages in- 
fected with W-E1  in the presence of rifampicin and then 
chased for 30 min. In single-labeling experiments, anti-IBV 
E1 labeled many of the smooth membranes connected to the 
viral buds  which had formed from the rifampicin bodies 
(Fig. 14 a). Double-labeling experiments showed colocaliza- 
tion of IBV E1 with p58 on some but not all of the smooth 
membranes around the rifampicin bodies (Fig. 14, b and c). 
Many of these membranes were continuous with the assem- 
bling virions (Fig.  14 b, large arrows). 
Collectively, these data argue that the membranes within 
the viral factories are not induced by the vaccinia infection 
but rather belong to the intermediate compartment of the 
host cell. Furthermore, in contrast to rab2, p53, or p58, IBV- 
E1 appeared to be more restricted in its localization. Only 
those vaccinia virions that assembled in regions close to the 
Golgi complex were  in  continuity with  IBV E1  enriched 
membranes. 
Lipid Analysis of Gradient-Purified INV and EEV 
If vaccinia virus really assembles from a cellular compart- 
ment,  the viral lipid composition should reflect the lipid 
composition of that compartment. We therefore determined 
the phospholipid composition of cesium chloride gradient- 
purified INV and EEV preparations and compared it with 
that of whole cells (Table 1I). The lipid composition of the 
cells was similar to published compositions (Wherrett and 
Huterer,  1972;  Stern and Dales,  1974; van Meer and Si- 
mons, 1982). When compared with whole cell extracts, INV 
was relatively deficient in sphingomyelin and phosphatidyl- 
serine while being enriched in phosphatidylinositol. Since 
sphingomyelin is thought to be synthesized in the cis-medial- 
Golgi apparatus (Futerman et al., 1990; Jeckel et al., 1990), 
its low concentration in the INN would be consistent with as- 
sembly on a compartment positioned before the Golgi stacks 
but after the ER (Fleischer et al.,  1974; van Meer,  1989). 
In contrast, compared with whole cell extracts as well as 
INV, purified EEV were enriched in sphingomyelin and phos- 
phatidylserine, and were relatively low in phosphatidylinosi- 
tol. Such a composition is more similar to late compartments 
of the secretory route (van Meer,  1989). 
As noted previously (Stern and Dales, 1974; Hiller et al., 
1981),  the INV  form of vaccinia virus was enriched in a 
phospholipid that ran close to the solvent front of the thin 
layer plate. This lipid has been tentatively identified as acyl- 
bis(monoacylglyceryl)phosphate  (Hiller et al., 1981), a lipid 
related to the lysosomal lipid bis(monoacylglyceryl)phos- 
phate  (Wherrett and  Huterer,  1972).  However, as  in the 
previous work (Hiller et al.,  1981),  an enrichment of this 
lipid was always accompanied by a decrease in the concen- 
tration of phosphatidylethanolamine. We are presently test- 
ing the possibility that the unknown lipid is the product of 
modification of phosphatidylethanolamine to N-acylphos- 
phatidylethanolamine, a lipid that has been observed and has 
a structure very similar to that of  acyl-bis(monoacylglyceryl)- 
phosphate (Somerharju and Renkonen, 1979). 
Figure 11. Immunoelectron microscopy of  cellular marker proteins for the intermediate compartment between the ER and the Golgi complex 
in vaccinia infected cells. Thawed cryosections of VV-WR infected HeLa cells at 8 h after infection were labeled with anti-rab2 (a) or 
with anti-p53 (b) followed by protein A-gold. The arrows (a) point to the two membranes within the assembling virions and to smooth 
membranes continuous with the virions. Anti-rab2 (arrowheads in a) labels membranes that are in part continuous with assembling virions 
(asterisk) as well as other membranes within the viral factories. Anti-p53 (arrowheads in b) labels membranes in close proximity to assem- 
bling virions (asterisk). Note the association of the gold particles for both anti-p53 and anti-rab2 with one cisterna of the Golgi complex 
(G; a and b). c and d show thawed cryosections of  J774 mouse macrophages infected with the recombinant VV-E1 incubated in the presence 
of rifampicin for 14.5 h and followed by 30 rain without rifampicin to accumulate immature viral particles. These sections were labeled 
with anti-p58 followed by protein A-gold. The arrows (c and d) point to the two membranes within the assembling virions and to smooth 
membranes continuous with the virions. Note the membranes in c (arrows) labeled for p58 (arrowheads) that appear to be continuous 
with the membranes of an assembling virion (asterisk). The double membranes of the latter are only visible in a small region of the viral 
crescents (/arge arrows), d shows continuities of the two membranes of assembling virions with a smooth membrane tubule or cisterna 
(arrows), which is labeled for p58 (arrowheads). Bars, 200 nm. 
Sodeik et al. Assembly of Vaccinia Virus  535 Figure 12. Immunofluorescence microscopy of IBV E1 expressed  by VV-E1 in HeLa cells.  HeLa cells infected with recombinant VV-E1 
in the absence (a, and b) or in the presence of  rifampicin (c-e) were labeled with anti-IBV E1 (a and c), with anti-p53 (b) or with a fluorescem 
DNA dye (e). d shows the corresponding phase contrast image to c and e. In infected cells p53 shows a strong perinuclear labeling  and 
some peripheral  punctate structures (b). Note that IBV E1 (a) labels a more restricted  region within the infected cell when compared with 
p53 (b).  In the presence of rifampicin (c-e) IBV E1 shows a similar  perinuclear labeling.  The rifampicin bodies (arrowheads in c and 
d) are also labeled,  although to a lesser extent.  The rifampicin  bodies occur predominantly in the region of the viral factory,  as defined 
by DNA staining  (e).  N, nucleus.  Bar,  10/~m. 
Discussion 
It has been thought for many years that Poxviridae acquire 
their first lipid envelopes by de novo biogenesis (Dales and 
Pogo, 1981; Palade,  1983; Petterson,  1991). This hypothesis 
was derived from detailed  electron microscopic studies of 
plastic embedded specimens, which failed to detect continui- 
ties between the membranes of assembling virions and cellu- 
lar organelles (Dales and Pogo,  1981; Moss,  1989).  In the 
present study,  we used thawed cryosections and antibodies 
The Journal of Cell Biology, Volume 121, 1993  536 Figure 13. Immunoelectron  microscopy of IBV E1 expressed by VV-E1 in HeLa cells. Thawed cryosections of HeLa ceils infected with 
recombinant VV-E1 for 4 h (a) or 8 h (b) were labeled with anti-IBV E1 followed by protein A-6 nm gold and with anti-p53 followed 
by protein A-9 nm gold (a) or with anti-IBV E1 followed by protein A-9 nm gold (b). a shows the colocalization of IBV E1 (arrows, 6 
nm gold) with p53 (arrowheads, 9 nm gold) on tubulovesicular membranes close to the nuclear envelope and to the Golgi complex (G) 
as well as on one or two cisternae on one side of the Golgi complex. The membranes within the viral factory where the immature virions 
(asterisk) assemble are labeled for IBV E1 (b). N, nucleus.  Bars, 200 nm. 
to several cellular antigens to show that the membranes of 
assembling virions are always in proximity to, and often con- 
tinuous with, smooth, tubulovesicular membranes of the in- 
termediate  compartment  between  the  ER  and  the  Golgi 
stacks.  The virions themselves were never labeled for any 
cellular marker protein we have looked at. These results sug- 
gest that vaccinia membranes are not synthesized de novo but 
derived from the intermediate compartment of the host cell. 
This idea is supported by the phospholipid composition of 
the newly formed virions that is intermediate between the 
known membrane composition of the ER and that of later 
secretory compartments (van Meer,  1989). 
The Intermediate Compartment in 
Vaccinia-infected Cells 
Our data show that four different markers of the intermediate 
compartment between the ER and the Golgi stacks, namely 
rab2, p53, p58, and in a more restricted fashion, the IBV El, 
localized to cellular membranes within the viral factories 
which were continuous with the membranes of assembling 
vaccinia virions.  Collectively,  these  data  suggest that  the 
membranes of the immature virions are derived from the in- 
termediate  compartment.  It is  clear  from this,  and  other 
studies,  that the membranes of the  intermediate compart- 
ment have an extensive structure of complex tubulo-vesicular 
organization. Much of their surface area consists of smooth 
tubules which, we assume, correspond to the tubular profiles 
evident in many of the published immunofluorescent images 
(e.g., Saraste et al.,  1987;  Schweizer et al.,  1988;  Lippin- 
cott-Schwartz et al.,  1989,  1990).  The organization of this 
region is especially obvious in thick sections of cells im- 
pregnated  with  osmium tetroxide  (Lindsey and  EUisman, 
1985a,b; Rambourg and Clermont,  1990).  All the markers 
for the intermediate compartment we have tested localize to 
one or two cisternae on one side of the Golgi stack, as well 
as to membrane profiles extending considerable distances 
from the Golgi region, both in infected (this paper) and un- 
infected cells (G. Grifiiths, unpublished data). However, the 
distribution of some of these markers was altered in vaccinia 
infected ceils. For example, by immunofluorescence micros- 
copy rab2  and  p53  were enriched  in  different  regions  of 
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Whether this finding reflects different functional domains of 
this organelle is an intriguing possibility which can only be 
determined when more information is available on the orga- 
nization and functions of this compartment. 
The idea of different subdomalns in the intermediate com- 
partment is supported by our observation that IBV E1 is more 
restricted in its localization when compared to the sites of 
vaccinia assembly as well as to rab2,  p53,  and p58.  Only 
those immature virions that assemble in close proximity to 
the Golgi stacks were in continuity with IBV E1  enriched 
membranes. IBV E1 has previously been considered to be- 
have as a Golgi resident protein (Machamer et al.,  1990). 
However, our data showing that much of this protein colocal- 
izes with p53 argues that, at least when expressed in vaccinia 
infected cells, the IBV E1  is either exclusively in the inter- 
mediate compartment or both in the intermediate compart- 
ment and in the cis-Golgi. The boundary between these two 
compartments  can  only  be defined  when  double-labeling 
studies are carried out to directly compare the localization 
of intermediate compartment markers with a bona fide resi- 
dent protein of  the cis-Golgi such as the Golgi mannosidase I. 
Assembly of Vaccinia Virus 
One mechanism by which vaccinia could acquire its mem- 
branes from the intermediate compartment would be by fol- 
lowing a budding mechanism similar to that used by other 
enveloped viruses  (Petterson,  1991;  Griffiths and  Rottier, 
1992). This budding would result in the acquisition of a sin- 
gle bilayer and would leave the virus within the lumen of the 
intermediate compartment. We were able to test this hypoth- 
esis by introducing an electron-dense marker, BSA gold, into 
the cytoplasm. The BSA-gold particles were excluded from 
cellular compartments but clearly had access to both sides 
of the viral crescents  as well as to immature and mature 
virions. We propose therefore that vaccinia virus becomes 
enwrapped by a membrane cisterna (Fig.  15). This proposal 
is consistent with the existence of the two membranes that 
are seen both in immature virions as well as in the INVs. In 
addition, this model explains how the immature virions, as 
well as the INVs, can acquire two membranes while still re- 
maining in the cytoplasm. We think that during the early 
steps in the assembly process the membranes of this cisterna 
are so tightly apposed that it is often difficult to distinguish 
the two bilayers. That two membranes do exist was shown 
by the protease treatment of perforated, infected cells. 
In our model an important question is how viral core pro- 
teins present in the factories become associated with the cel- 
lular membranes of the intermediate compartment. It seems 
likely that viral core proteins bind to so far unidentified viral 
transmembrane protein(s) that are targeted to the intermedi- 
ate compartment, resulting in the formation of the crescents 
l.C.  I.e. 
CRESCENT  IV  INTERMEDIATE 
INV/IMV  IEV  EEV 
Figure 15. Model for vaccinia virus assembly. During the first en- 
velopment step, a viral crescent is formed from cellular membranes 
derived  from the  intermediate  compartment  (LC.; arrowheads). 
When  the  envelopment has been completed,  an immature  virus 
(/V)  containing  two tightly apposed membranes is formed.  The 
morphologically distinct spicules of the crescents as well as the IV 
are indicated as lines in the outer membrane.  These spicules be- 
come less visible as the virus matures.  During the maturation of 
the virus particle, an intermediate form is seen in which two mem- 
branes become clearly  visible;  the  inner one acquires the brick 
shape of  the INV, while the outer membrane profile remains spheri- 
cal. The next viral particle that is formed is the INV/IMV (intracel- 
lular  naked virus or intracellular  mature  virus; see Discussion) 
where both membrane profiles are brick shaped. The INV becomes 
enwrapped by another cellular cisterna thereby forming the four- 
membraned  intracellular  enveloped virus (IEV). The IEV is be- 
lieved to  fuse  with  the  plasma membrane,  releasing  the  three- 
membraned extracellular enveloped virus (EEV) into the medium. 
Note that this model ignores the problem of how the DNA, which 
is found within  the  intermediate  particle,  enters  the  assembling 
virus. 
and  subsequently  the  immature virions.  The(se)  putative 
vaccinia membrane protein(s) might be a useful tool in future 
studies of the intermediate compartment. 
The assembly model we are proposing (Fig.  14)  is sup- 
ported by the presence of a viral form that is intermediate 
between the  spherical  immature virus and  the  INV.  This 
form shares the spherical appearance of the immature virus, 
but it is more electron dense than the immature virus and in 
this form two membranes become visible. The term "intra- 
cellular naked virus" (INV) has long been used to refer to 
mature, infectious, intracellular vaccinia virus. In addition 
to being misleading, the name implies that the virus lacks a 
lipid envelope, which is clearly not the case. Thus, we pro- 
pose that this virus should in the future be referred to as "in- 
tracellular mature virus" (IMV) which specifies the intracel- 
Figure 14. Immunoelectron  microscopy of IBV E1 expressed by VV-E1 in mouse macrophage cells. J774 mouse macrophages infected 
with VV-E1 for 14 h were incubated in the presence of rifampicin for 13.5 h and then without rifampicin for 30 min to accumulate viral 
crescents (asterisks). During the last 2 h of infection, cycloheximide was added to the culture medium. Thawed cryosections were labeled 
with anti-IBV E1 followed by protein A-6 run gold (a) or double labeled (b and c) with anti-IBV E1 (protein A-6 nm gold) and with anti-p58 
(protein A-9 nm gold). Anti-E1 (a) labels the smooth membranes (small arrows) in close proximity to the viral crescents (/arge arrows 
in a and b indicate the membranes of the crescents) which are formed from the rifampicin bodies (R). Double-labeling experiments (b 
and c) show colocalization of IBV E1 (small arrows) with p58 (arrowheads) on the same smooth membranes around the rifampicin bodies 
(R) which are in continuity with,  or in close proximity to the assembling virions  (/arge arrows in b). Bars, 200 nm. 
Sodeik et al. Assembly  of Vaccinia Virus  539 lular location as well as the infectious nature of this virus 
particle. 
In summary, our data indicate that vaccinia virus is the 
first enveloped virus shown to become enwrapped by two 
membranes simultaneously. The end result of this process is 
the production of the infectious INV/IMV. This process is 
repeated  when  the  INV/IMV  is  engulfed  by  a  second 
cisterna.  The cellular origin of this second cisterna as well 
as the molecular mechanisms involved in these unique as- 
sembly processes will be the focus of our future studies. 
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